Skip to content

Integrative Evolutionary and Structural Analysis of GBA1 Provides Insights Into Mutation‐Specific Effects Associated With Parkinson's Disease

Oct 2026 · European Journal of Neuroscience · Vol 64 · 0 citations · 88 references
Medicine

TL;DR

Findings highlight candidate structural determinants for future experimental studies of GBA1-associated neurodegeneration and identify evolutionarily constrained features of GBA1 that may influence its interaction with α-synuclein (SNCA) and thereby contribute to PD pathogenesis.

Abstract

GBA1 encodes lysosomal acid β‐glucosidase (glucocerebrosidase [GCase]), a key lysosomal enzyme and one of the most important genetic factors in Parkinson's disease (PD). Yet how different GBA1 variants influence PD‐related molecular pathology remains incompletely understood. Here, we integrated phylogenetic, comparative sequence, structural, docking, and molecular dynamics analyses to identify evolutionarily constrained features of GBA1 that may influence its interaction with α‐synuclein (SNCA) and thereby contribute to PD pathogenesis. Phylogenetic reconstruction indicated that GBA1 originated early in bilaterian evolution and was maintained as a single‐copy gene in the sampled taxa, consistent with strong functional constraint. Sequence‐based analyses across sarcopterygian lineages further supported pervasive purifying selection, especially within the TIM barrel catalytic domain. Comparative structural analyses highlighted a conformationally sensitive segment spanning Residues 379–389, which includes catalytic and neighboring residues and showed recurrent involvement in both mammalian evolution and PD‐associated mutant proteins. Docking and molecular dynamics simulations of wild‐type and mutant GBA1–SNCA complexes indicated that PD‐associated substitutions can remodel hydrogen‐bond networks and influence the conformational landscape of the GBA1–SNCA complex in a mutation‐specific manner. Although no statistically significant differences in global structural or energetic properties were detected, individual variants exhibited distinct patterns of conformational deviation, flexibility, and interaction dynamics relative to wild type. In particular, Residues 387–389 emerged as part of a structurally responsive region linked to altered GBA1–SNCA association. Together, these findings highlight candidate structural determinants for future experimental studies of GBA1‐associated neurodegeneration.

View source

Similar papers

#protein folding Open access Sep 2026

Molecular and Structural Characterization of Five Novel GLA Gene Variants in Fabry Disease

Overall, these findings support an effect of the five variants on α-galactosidase A structure and function and highlight the value of integrating clinical, genetic, biochemical, and computational data for variant interpretation.

Monia Anania, V. Pagliardini, Marco Spada et al. · 0 citations
Open access Sep 2026

Evolutionary analysis of PINK1 reveals key roles of the N- and C-terminal extensions and TOM20 in folding its kinase domain

These findings support a model in which the NTE and CTE act as intramolecular determinants of PINK1 kinase stability and suggest that vertebrate PINK1 has evolved an increased dependence on the mitochondrial import machinery to maintain a functional state.

Tara Shomali, S. Veyron, J. Trempe · 0 citations
Review Open access Oct 2026

Protein structure–function relationships as the molecular basis of phenotypic diversity in GDAP1-associated Charcot–Marie–Tooth disease

Mutations in the GDAP1 gene, which encodes the ganglioside-induced differentiation-associated protein 1 (GDAP1)—a member of the detoxifying glutathione S-transferase (GST) superfamily—cause Charcot–Marie–Tooth disease (CMT) a genetically heterogeneous group of inherited neuropathies. This mini review correlates the cli...

V. Bunik, A. Emelyanova · 0 citations
Oct 2026

Identification of novel CDK19 variants and Drosophila-based in vivo functional evidence supporting pathogenicity in neurodevelopmental disorders.

PURPOSE CDK19 (HGNC:19338) is a Mediator-associated kinase that regulates transcription during neurodevelopment. Although CDK19 variants have been linked to neurodevelopmental disorders, the full phenotypic spectrum and underlying pathogenic mechanisms remain incompletely defined. We aimed to further characterize clini...

Hyun Yong Koh, R. Sahu, Sung Dae Kim et al. · 0 citations
Conference Open access Oct 2026

Upstream and Downstream Convergence: How do the GBA1 and LRRK2 genes disrupt PINK1/Parkin-Mediated Mitophagy?

Parkinson’s Disease (PD) is a complex progressive neurodegenerative disease with certain cases exhibiting non-idiopathic forms. Understanding this allows for a better understanding about the disease and treatment options. The 2 main genetic forms of PD are mutations in the Glucosylceramidase Beta 1 (GBA1) and Leucine-R...

Nikhil Rahul · 0 citations
Open access 2026

In Silico Characterization of the Human Parkin Protein and Hypothetical Crispr/Cas9 Gene Editing Design for Modeling Parkinsonism

PRKN-associated parkinsonism represents one of the most prominent genetic causes of early-onset autosomal recessive parkinsonism. This study reports an exploratory in silico characterization of the human PRKN gene and a theoretical CRISPR/Cas9 gene editing design for exon disruption. Using genomic and protein databases...

Arya Rajmohan · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.